Ignite Creation Date:
2026-03-26 @ 3:18 PM
Ignite Modification Date:
2026-03-31 @ 7:47 AM
Study NCT ID:
NCT07401251
Status:
NOT_YET_RECRUITING
Last Update Posted:
2026-02-10
First Post:
2026-02-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Lead Exposure Intervention Program
Sponsor:
University of Washington
Organization:
Study Overview
Official Title:
Lead Exposure Intervention Program
Status:
NOT_YET_RECRUITING
Status Verified Date:
2026-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
LEIP
Brief Summary:
The goal of this clinical trial is to learn if BLL (blood lead level) screening and "healthy home" lead prevention program created in the US is adaptable to a Sub-Saharan African context. It will also work to address child lead exposure in Nairobi, Kenya. The main questions it aims to answer is:
* Can materials and protocols developed for a US audience be effective in a Sub-Saharan African one?
* Is there a difference in learning and action between groups that receive different degrees of intervention?
Researchers will compare the outcomes of a group that received lead risk reduction information only in the clinical setting to a group that also received a home visit and tailored risk reduction messages.
Participants will:
* Have their child's blood lead levels measured at several timepoints
* Take part in a questionnaire about lead risk
* Receive lead risk reduction messaging either only in the clinic setting or also in their homes
* Have their knowledge and risk reduction behaviors measured
* Can materials and protocols developed for a US audience be effective in a Sub-Saharan African one?
* Is there a difference in learning and action between groups that receive different degrees of intervention?
Researchers will compare the outcomes of a group that received lead risk reduction information only in the clinical setting to a group that also received a home visit and tailored risk reduction messages.
Participants will:
* Have their child's blood lead levels measured at several timepoints
* Take part in a questionnaire about lead risk
* Receive lead risk reduction messaging either only in the clinic setting or also in their homes
* Have their knowledge and risk reduction behaviors measured
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| 1R01ES036010 | NIH | None | https://reporter.nih.gov/quic… | View |